Position in CYTK
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$25,949,811
+$6,126,588 QoQ
Shares Held
304,611
+1.3% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#76
of 477 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026E. Ohman J:or Asset Management AB holds $53,160,442 across 15 Biotechnology names. CYTK ranks #1 (48.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
This page
|
304,611 | $25,949,811 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,823 | $4,382,648 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
160,000 | $4,115,200 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
385,000 | $3,780,700 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
85,777 | $3,680,691 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
45,794 | $2,882,274 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,840 | $2,394,393 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,584 | $1,379,921 |
All Filings in CYTK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,949,811 | 304,611 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $19,823,223 | 300,762 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $23,062,605 | 362,962 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $22,370,753 | 407,037 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $13,448,502 | 407,037 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $13,231,793 | 329,231 | Shares | Sole | 2025-04-11 | |
| No filing history on record for this holder in this stock. | ||||||